Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure

Nephrology Dialysis Transplantation

Volumn 22, Issue 2, 2007, Pages 529-537

  Fiaccadori, Enrico ^a   Maggiore, Umberto ^a   Parenti, Elisabetta ^a   Giacosa, Roberto ^a   Picetti, Edoardo ^a   Rotelli, Carlo ^a   Tagliavini, Dante ^a   Cabassi, Aderville ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Acute kidney failure; Critical illness; Epoprostenol; Intensive care unit; Prostacyclin; SLED; Sustained low efficiency dialysis

Indexed keywords

BICARBONATE; HYPERTENSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; PROSTACYCLIN; SODIUM CHLORIDE; UREA;

ACUTE KIDNEY FAILURE; ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD FLOW; CRITICALLY ILL PATIENT; DIALYSATE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; HEMATOCHEZIA; HUMAN; HYPOTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MELENA; MORTALITY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SCORING SYSTEM; SEPSIS; THROMBOSIS; ULTRAFILTRATION;

AGED; CRITICAL ILLNESS; DIALYSIS SOLUTIONS; EPOPROSTENOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MALE; PLATELET AGGREGATION INHIBITORS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846663618     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl627     Document Type: Article

References (37)

1. Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000; 36: 294-300
2. Marshall M, Golper T, Shaver M et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001; 60: 777-785
3. Marshall MR, Ma T, Galler D, Rankin AP, Williams AB. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: Towards an adequate therapy. Nephrol Dial Transplant 2004; 19: 877-884
4. Kielstein JT, Kretschmer U, Ernst T et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: A randomized controlled study. Am J Kidney Dis 2004; 43: 342-349
5. Berbece AN, Richardson RM. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int 2006; 19 July [Epub ahead of print]; doi:10.1038/sj.ki.5001700
6. Marshall MR, Golper TA. Sustained low efficiency or extended daily dialysis. Up to date 2006, online version 13.3.
7. Flieser D, Kielstein JT. Technology insight: Treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol 2006; 2: 32-39
8. Vanholder R, Van Biesen W, Lameire N. What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol 2001; 12: S40-S43
9. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: The incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003; 29: 575-578
10. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C. ADQI workgroup. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002; 62: 1855-1863
11. Marshall MR, Ma TM, Eggleton K, Ferencz A. Regional citrate anticoagulation during simulated treatments of sustained low efficiency diafiltration. Nephrology 2003; 8: 302-310
12. Morgera S, Scholle C, Melzer C et al. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure. Nephron Clin Pract 2004; 98: C35-c40
13. Finkel KW, Foringer JR. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients. Ren Fail 2005; 27: 541-545
14. Scheeren T, Radermacher P. Prostcyclin (PGI2): New aspects of an old substance in the treatment of critically ill patients. Intensive Care Med 1977; 23: 146-158
15. Kozek-Langenecker SA, Spiss CK, Michalek-Sauberer A, Felfernig M, Zimpfer M. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Crit Care Med 2003; 31: 864-868
16. Fiaccadori E, Maggiore U, Rotelli C et al. Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Med 2002; 28: 586-593
17. Ponikvar R, Kandus A, Buturivic J, Kveder R. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration. Contrib Nephrol 1991; 93: 218-220
18. Zobel G, Trop M, Muntean W, Ring E, Gleispach H. Anticoagulation for continuous arteriovenous hemofiltration in children. Blood Purif 1988; 6: 90-95
19. Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 1994; 22: 1774-1781
20. Kozek-Langenecker SA, Spiss CK, Gamsjager T, Domenig C, Zimpfer. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: A randomized controlled trial. Wien Klin Wochenschr 2002; 114: 96-101
21. Fiaccadori E, Lombardi M, Leonardi S, Rotelli CF, Tortorella G, Borghetti A. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: A prospective cohort study. J Am Soc Nephrol 1999; 10: 581-593
22. Fiaccadori E, Maggiore U, Lombardi M, Leonardi S, Rotelli C, Borghetti A. Predicting patient outcome from acute renal failure comparing three general severity of illness scoring systems. Kidney Int 2000; 58: 283-292
23. Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A. Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int 2001; 59: 1510-1519
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
25. Parker RA, Himmelfarb J, Tolkoff-Rubin N, Chandran P, Wingard RL, Hakim RM. Prognosis of patients with acute renal failure requiring dialysis: results of a multicenter study. Am J Kidney Dis 1998; 32: 432-443
26. Marshall MR, Golper TA, Shaver MJ et al. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 2002; 39: 556-570
27. Paine RW. REML analysis of mixed models. In: Paine RW, ed. The Guide To GenStat 8.0. Part 2: Statistics, VSN International, Oxford: 2005; 513-698
28. Diggle PJ, Liang KY, Zeger SL. Parametric models for covariance structure. Analysis of Longitudinal Data, Oxford Science Publications, Oxford: 1996; 78-116
29. Rogers WH. Regression standard errors in clustered samples. Stata Technical Bulletin 1993; 3: 88-94
30. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute and hepatic failure. Nephron 1994; 66: 431-437
31. Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: A retrospective study. Am J Kidney Dis 1994; 24: 806-812
32. Van de Wetering J, Westendorp RGJ, van der Hoeven JG, Feuth JDM, Chan PC. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; 7: 145-150
33. Ronco C, Bellomo R, Homel P et al. Effect of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000; 355: 26-30
34. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 1993; 41 [Suppl]: S237-S244
35. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 2002; 30: 2205-2211
36. Schortgen F, Soubrier N, Delclaux C et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: Usefulness of practice guidelines. Am J Respir Crit Care Med 2000; 162: 197-202
37. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR. Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based? Intensive Care Med 2006; 32: 188-202